Matching-adjusted indirect comparison (MAIC) of safety outcomes with MET tyrosine kinase inhibitors (TKIs) in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Taylor, K.; Veillon, R.; Griesinger, F.; Reinmuth, N.; Ghori, V.; Vioix, H.; Clark, A.; Paik, P.
Abstract Title: Matching-adjusted indirect comparison (MAIC) of safety outcomes with MET tyrosine kinase inhibitors (TKIs) in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
Meeting Title: ISPOR Europe 2024
Journal Title: Value in Health
Volume: 27
Issue: 12 Suppl.
Meeting Dates: 2024 Nov 17-20
Meeting Location: Barcelona, Spain
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2024-12-01
Start Page: S40
End Page: S41
Language: English
ACCESSION: WOS:001462343900160
PROVIDER: wos
DOI: 10.1016/j.jval.2024.10.215
Notes: Meeting Abstract: CO139 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik